Drug Profile
Research programme: NAALADase inhibitors - MGI GP
Alternative Names: 2-MPPA; GPI 16476; GPI 16477; Small molecule pre-synaptic glutamate inhibitorsLatest Information Update: 20 Feb 2008
Price :
$50
*
At a glance
- Originator MGI GP
- Class Small molecules
- Mechanism of Action Glutamate carboxypeptidase II inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurodegenerative disorders; Neuropathic pain; Prostate cancer; Substance-related disorders
Most Recent Events
- 31 Dec 2007 Discontinued - Preclinical for Neurodegenerative disorders in USA (unspecified route)
- 31 Dec 2007 Discontinued - Preclinical for Neuropathic pain in USA (unspecified route)
- 31 Dec 2007 Discontinued - Preclinical for Prostate cancer in USA (unspecified route)